Gadolinium(III) complex formation with a β-cyclodextrin ligand: an XAS study of a potential MRI contrast agent
JBIC Journal of Biological Inorganic Chemistry · 2023
DOI: 10.1007/s00775-023-02027-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift JBIC Journal of Biological Inorganic Chemistry, 2023. Verfasst von Farideh Jalilehvand und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada. faridehj@ucalgary.ca. Hauptthemen laut MEDLINE: Cyclodextrins, beta-Cyclodextrins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, The Canadian Lightsource.
Abstract (Originalsprache)
In the search for improved and safer gadolinium-based magnetic resonance imaging (MRI) contrast agents, macrocyclic cyclodextrins (CDs) attract great interest. Our group previously synthesized a cyclodextrin-based ligand with 1,2,3-triazolmethyl residues conjugated to β-CD, called β-CD(A), which efficiently chelates Gd(III) ions. To probe the local structure around the Gd(III) ion in the 1:1 Gd(III): β-CD(A) complex in aqueous solution (pH 5.5), we used extended X-ray absorption fine structure (EXAFS) spectroscopy. Least-squares curve fitting of the Gd L3-edge EXAFS spectrum revealed 5 Gd-O (4 COO- and 1 H2O) and 4 Gd-N (from two imino and two 1,2,3-triazole groups) bonds around the Gd(III) ion with average distances 2.36 and 2.56 ± 0.02 Å, respectively. A similar EXAFS spectrum was obtained from an aqueous solution of the clinically used MRI contrast agent Na[Gd(DOTA)(H2O)], also 9-coordinated in its first shell. Careful analysis revealed that the mean Gd-N distance is shorter in the Gd(III): β-CD(A) (1:1) complex, indicating stronger Gd-N bonding and stronger Gd(III) complex formation than with the DOTA4- ligand. This is consistent with the lower free Gd3+ concentration found previously for the Gd(III): β-CD(A) (1:1) complex than for the [Gd(DOTA)(H2O)]- complex, and shows its potential as an MRI probe. EXAFS spectroscopy revealed a similar Gd(III) 9-coordination although slightly stronger for a modified β-cyclodextrin: Gd(III) 1:1 complex, [Gd(LH4)]7-, in aqueous solution than for the clinically used MRI contrast agent Na[Gd(DOTA)(H2O)].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada. faridehj@ucalgary.ca.
- Department of Chemistry, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada.
- Department of Chemistry, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada. ccling@ucalgary.ca.
ORCID-Profile: Farideh Jalilehvand, Chang-Chun Ling
Förderung
- Canada Foundation for Innovation
- Natural Sciences and Engineering Research Council of Canada
- The Canadian Lightsource
Zitieren
APA
Jalilehvand, F., Homayonia, S., Zhang, P., & Ling, C. C. (2023). Gadolinium(III) complex formation with a β-cyclodextrin ligand: an XAS study of a potential MRI contrast agent. JBIC Journal of Biological Inorganic Chemistry. https://doi.org/10.1007/s00775-023-02027-9
Vancouver
Jalilehvand F, Homayonia S, Zhang P, Ling CC. Gadolinium(III) complex formation with a β-cyclodextrin ligand: an XAS study of a potential MRI contrast agent. JBIC Journal of Biological Inorganic Chemistry. 2023. doi:10.1007/s00775-023-02027-9
BibTeX
@article{Jalilehvand2023,
author = {Jalilehvand, Farideh and Homayonia, Saba and Zhang, Ping and Ling, Chang-Chun},
title = {Gadolinium(III) complex formation with a β-cyclodextrin ligand: an XAS study of a potential MRI contrast agent},
journal = {JBIC Journal of Biological Inorganic Chemistry},
year = {2023},
doi = {10.1007/s00775-023-02027-9}
}
EUVIMED